RAPID INFUSER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Rapid Infuser Market Size and Trends

Global rapid infuser market is estimated to be valued at USD 796.9 Mn in 2024 and is expected to reach USD 1,109 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

To learn more about this report, request sample copy

Rapid infusion devices have witnessed increased adoption in the recent years due to growing demand for emergency blood infusion in trauma and surgery cases. Rapid infusion devices offer standardized and controlled infusion, thus, helping medical staff focus on critical patient care. Developed markets in North America and Europe currently account for majority of demand for rapid infusion devices. However, Asian markets are expected to witness highest growth during the forecast period supported by rising medical infrastructure, healthcare expenditure and greater focus on patient safety.

Rising incidences of internal hemorrhage

The rate of internal hemorrhage associated injuries has witnessed a steady rise over the past decade  due to traumatic injuries caused in accidents or non-traumatic hemorrhaging occurring owing to medical conditions such as gastrointestinal bleeding, uterine bleeding post childbirth, ruptured ectopic pregnancies, and others. Rapid administration of blood products is critical in managing massive hemorrhage to prevent fatality. Traditionally blood transfusion has been a lengthy process involving manual extraction and administration of packed red cells from banks. With delayed intervention, the rate of mortality increases substantially. Rapid infusers address this challenge effectively. These devices can automatically extract blood from bags/containers and infuse it into the patient in a controlled manner but at a much faster pace compared to traditional methods. Some advanced rapid infuser models have the capability to accurately measure blood components being administered and regulate the flow and volume infused. This ensures blood is supplied to the patient efficiently without any delays due to automated processes but also in a safe controlled method.

Over the past few years, patient blood management has emerged as a pivotal strategy adopted across hospital settings to improve patient safety, clinical outcomes and optimize transfusion practices. It involves applying evidence-based medical and surgical concepts designed to maintain hemoglobin levels and optimize hemodynamic status without exposing patients to unnecessary allogeneic blood transfusions. Traditional blood transfusion practices relied on manual methods to extract and infuse blood, which were cumbersome and time consuming. With patient blood management gaining international recognition, rapid infusion technology addresses one of the core challenges viz timely fluid resuscitation.